# AVGEMSI

NDC: 83831-124
Generic name: Gemcitabine
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250803

FDA application: NDA219920

## Active ingredients

- GEMCITABINE HYDROCHLORIDE: 38 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-124"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-124
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e11eeff7-bcaf-4bf1-8da8-88138e01af84